Results 1 to 10 of about 207,050 (299)

Incidental prostate-specific membrane antigen-avid glioblastoma detected on 68Ga–prostate-specific membrane antigen PET/CT

Radiology Case Reports, 2022
A 74-year-old man was referred for a 68Ga–prostate-specific membrane antigen (PSMA) PET/CT scan for newly diagnosed prostate cancer which confirmed the presence of PSMA avid cancer in the right gland with no evidence of PSMA metastasis.
James Yuheng Jiang, MD, MMed, Christine Kang, MD, MMed, Paul Bui, MBBS, FRANZCR, FAANMS, Robert Mansberg, MBBS, FRACP, FAANMS   +3 more
doaj   +3 more sources

Incidental prostate-specific membrane antigen-avid meningioma detected on 68Ga–prostate-specific membrane antigen PET/CT

Radiology Case Reports, 2021
A 70-year-old gentleman with a history of Gleason score 7 (3 + 4) prostate adenocarcinoma was treated with radical prostatectomy with clear surgical margins. Postoperatively his prostate specific antigen was undetectable.
James Yuheng Jiang, MD, MMed (ClinEpi), Joshua Wei Liang Yip, MBBS, Christine Kang, MD, MMed (ClinEpi), Vu Hoang Tran, MD, Marco Enoch Lee, MD, Ken Le, MBBS, FRANZCR, Robert Mansberg, MBBS, FRACP, FAANMS   +6 more
doaj   +3 more sources

Biomarkers in Prostate-Specific Membrane Antigen Theranostics [PDF]

Diagnostics, 2021
Theranostics of prostate cancer (PC) represents a growing area of development of imaging agents and targeted radionuclide therapeutics against a major target, prostate specific membrane antigen (PSMA).
Panagiotis J. Vlachostergios, Ioannis Zachos, Vassilios Tzortzis   +2 more
doaj   +3 more sources

Cancer Patient T Cells Genetically Targeted to Prostate-Specific Membrane Antigen Specifically Lyse Prostate Cancer Cells and Release Cytokines in Response to Prostate-Specific Membrane Antigen [PDF]

Neoplasia: An International Journal for Oncology Research, 1999
The expression of immunoglobulin-based artificial receptors in normal T lymphocytes provides a means to target lymphocytes to cell surface antigens independently of major histocompatibility complex restriction.
Michael C. Gong, Jean-Baptiste Latouche, Anja Krause, Warren D.W. Heston, Neil H. Bander, Michel Sadelain   +5 more
doaj   +3 more sources

Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen [PDF]

Current Oncology
Prostate cancer represents a significant public health challenge, with its management requiring precise diagnostic and prognostic tools. Prostate-specific membrane antigen (PSMA), a cell surface enzyme overexpressed in prostate cancer cells, has emerged ...
Omar Tayara, Sławomir Poletajew, Wojciech Malewski, Jolanta Kunikowska, Kacper Pełka, Piotr Kryst, Łukasz Nyk   +6 more
doaj   +2 more sources

Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA) [PDF]

, 2013
The aim of this study was to identify potential ligands of PSMA suitable for further development as novel PSMA-targeted peptides using phage display technology. The human PSMA protein was immobilized as a target followed by incubation with a 15-mer phage
A Ghosh, AC Pawlyk, AM Quinn, CW Diehnelt, D Hessels, D Shen, DB Sodee, Duanwen Shen, E Basch, F Yi, Fei Xie, GA Lazar, H Liu, H Liu, H-S Lim, HD Agnew, IM Thompson, Irina U. Agoulnik, J Yu, JA Arter, JR Mesters, JR Newton, KA Noren, MI Davis, MI Milowsky, MJ Morris, MJ Morris, MJ Roobol, NH Bander, RK Nam, S Aggarwal, S Kim, S Minner, SE Lupold, SM Hillier, SR Banerjee, SR Banerjee, SR Banerjee, SR Banerjee, SS Chang, SZ Li, TJ Wigle, V Humblet, W. Barry Edwards, Y Chen, Y Chen, Y Chen, Z Xiao, ZY Zhu   +48 more
core   +20 more sources

A Review of Prostate Cancer and the Effect of Lutetium Radiopharmaceutical [PDF]

Translational Research in Urology, 2023
Introduction: Prostate cancer is a type of disease in which malignant cells originate from prostate tissue and multiply irregularly and increasingly, leading to an increase in volume in each of the cellular components of the prostate gland.  Methods: The
Akram Amani, Bentolhoda Rashidi
doaj   +1 more source

18F DCFPyL PSMA avid biopsy proven subcutaneous capillary haemangioma as a malignancy mimic in the setting of biochemical recurrent prostate carcinoma

Radiology Case Reports, 2022
We present a case of a 65-year-old male with a biopsy proven subcutaneous capillary haemangioma identified on imaging for evaluation of further metastatic spread of prostatic carcinoma due to a rise in his prostate-specific antigen biochemistry.
Manvinder Dhillon, MBBS, BMedSci, PGDAAD, MS, Dalveer Singh, MBBS, FRANZCR, FAANMS   +1 more
doaj   +1 more source

PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?

Therapeutic Advances in Medical Oncology, 2021
Prostate-specific membrane antigen (PSMA) is highly expressed on the membrane of most prostate cancer cells and to a lesser extent in normal tissues. Many vectors targeting this protein have been created over the past decade and numerous clinical studies
Anne-Laure Giraudet, David Kryza, Michael Hofman, Aurélie Moreau, Karim Fizazi, Aude Flechon, Rodney J. Hicks, Ben Tran   +7 more
doaj   +1 more source

A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial

Clinical and Translational Radiation Oncology, 2022
Background and purpose: The treatment of biochemical recurrence (BCR) after prostatectomy is challenging as the site of the recurrence is often undetectable.
Adalsteinn Gunnlaugsson, Vilberg Johannesson, Elinore Wieslander, Eva Brun, Ulrika Bitzén, Olof Ståhl, Ola Bratt, Göran Ahlgren, Tomas Ohlsson, Elisabeth Kjellén, Per Nilsson   +10 more
doaj   +1 more source